Prevention of T Cell Anergy by Signaling Through the γ <sub>c</sub> Chain of the IL-2 Receptor
Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Lee M. Nadler(Dana-Farber Cancer Institute), Dwayne L. Barber(University of Toronto), Alan D. D’Andrea(Dana-Farber Cancer Institute), John G. Gribben(Queen Mary University of London), Gordon J. Freeman(Dana-Farber Cancer Institute), Takayuki Nakarai(Institut Pasteur), Gregory M. Bernstein(Dana-Farber Cancer Institute), Jerome Ritz(Dana-Farber Cancer Institute)
Cited by 312
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k